Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
46.80    0.45 (0.97%)
Bid:
46.60
Ask:
46.85
Spread: 0.25 (0.536%)
Market Cap: £296.18m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

29 Jun 2022 08:45

RNS Number : 6164Q
Marston's PLC
29 June 2022
 

Marston's PLC (the "Company") has been informed that, on 27 June 2022, a grant of share options was made to the following Directors under the Company's Sharesave Scheme. The savings contract will commence on 1 September 2022 and the share option price is £0.44. Options granted under the Scheme are currently satisfied using market purchase shares.

 

Name

Status

Number of shares under option

Date on which exercisable

Andrew Andrea

Director and PDMR

40,909

1 September 2025

Hayleigh Lupino

Director and PDMR

40,909

1 September 2025

 

The relevant notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of PDMR / PCA (person closely associated)

 

(a)

Name

Andrew Andrea

 

(b)

Position/status

Director and PDMR (Chief Executive Officer)

 

(c)

Initial notification/ amendment

Initial notification

 

2.

Details of the issuer

 

(a)

Name

Marston's PLC

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

 

ISIN GB00B1JQDM80

 

(b)

Nature of the transaction

Grant of option under the Sharesave Scheme

 

(c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.44

40,909

(d)

Aggregated information

- Aggregated volume

- Price

 

n/a single transaction

 

(e)

Date of the transaction

 

2022-06-27

(f)

Place of the transaction

 

Outside a trading venue

 

 

1.

Details of PDMR / PCA (person closely associated)

 

(a)

Name

Hayleigh Lupino

 

(b)

Position/status

Director and PDMR (Chief Financial Officer)

 

(c)

Initial notification/ amendment

Initial notification

 

2.

Details of the issuer

 

(a)

Name

Marston's PLC

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

 

ISIN GB00B1JQDM80

 

(b)

Nature of the transaction

Grant of option under the Sharesave Scheme

 

(c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.44

40,909

(d)

Aggregated information

- Aggregated volume

- Price

 

n/a single transaction

 

(e)

Date of the transaction

 

2022-06-27

(f)

Place of the transaction

 

Outside a trading venue

 

 

Enquiries: Bethan Raybould, General Counsel & Company Secretary

Marston's PLC

+44 (0) 1902 329163

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAXKNALSAEEA
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.